
    
      Patients will be administered 6 cycles of combination chemotherapy, unless withdrawn earlier
      due to unacceptable toxicity, disease progression, or consent withdrawal. Patients will
      continue to be treated with trastuzumab alone until disease progression, unacceptable
      toxicity or consent withdrawal after finishing a maximum 6 cycles of combination
      chemotherapy.
    
  